Pharmacologic Treatment of Acquired Ptosis: A Win-Win for Patients and Practices

Treating blepharoptosis (‘ptosis’) has traditionally been the domain of the oculoplastic surgeon. As patients’ primary eye care providers, optometrists have grown used to identifying and monitoring ptosis, and if the patient is motivated, making a referral for a surgical consultation, but otherwise taking a more conservative ‘watch-and-wait’ approach.

Sponsored by Osmotica Pharmaceuticals